Lupin-Natco get USFDA nod to market generic hypertension drug – Moneycontrol

The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement. Read More